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Abstract 
Background: Resistance to the artemisinin derivatives in Plasmodium falciparum has emerged in Cambodia and is 
now spreading throughout South-East Asia. The rapid elimination of P. falciparum seems to be the only viable option 
to avoid a public health disaster but this is difficult because even in low transmission settings many residents have 
asymptomatic parasitaemias.
Methods: In response to a large number of malaria cases reported in three remote villages on the Thai-Myanmar 
border where malaria is endemic and the disease is seasonal, surveys were conducted using an ultra-sensitive qPCR 
assay (LOD 22 parasites per mL). In one of the villages where it was feasible, mass anti-malarial drug administration 
was proposed to the population as a potential solution, and this was adopted.
Results: In the three villages 204/356 (57.3 %), 212/385 (55.1 %) and 195/286 (68.2 %) of the resident populations 
were positive by qPCR (approximately one-third P. falciparum and two-thirds P. vivax). Of those positive for P. falcipa-
rum 62 % carried single point mutations in the P. falciparum kelch protein (a marker of artemisinin resistance). In one 
of the villages 217 of 674 inhabitants received at least one dose of dihydroartemisinin-piperaquine chemoprevention 
in June 2012, 155 (71.4 %) received two consecutive months, and 98 (45.2 %) received three treatment doses. The 
chemoprevention was generally well tolerated. The sub-microscopic reservoir of P. falciparum malaria was eliminated 
during the six-month follow-up period (prevalence fell from 7 to 0 %); P. vivax malaria persisted (prevalence fell from 
35 to 8 %). From June to October 2012 (rainy season) the number of clinical episodes of P. falciparum was six times 
lower (46), than during the same period in the previous year (290).
Conclusion: Mass drug administration with dihydroartemisinin-piperaquine may be an effective strategy to elimi-
nate P. falciparum rapidly where multi-drug resistance is present.
© 2015 Lwin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The emergence and spread from Asia to Africa of first 
chloroquine resistance and then anti-folate resistance 
in P. falciparum led to the loss of millions of lives. Rela-
tive resistance to artemisinin derivatives has emerged 
recently in Western Cambodia making it imperative to 
eliminate these parasites rapidly to prevent their spread 
across Asia to Africa and another disastrous upsurge in 
malaria mortality. Although this apparently has now 
the highest priority for malaria control programmes [1], 
a consensus on how this can be best achieved is yet to 
be reached. Current strategies and plans provide little 
detailed guidelines [2, 3] and the continued strengthening 
of existing malaria control measures has failed to prevent 
the westward spread of artemisinin resistant parasites [4]. 
Treating symptomatic patients and preventing transmis-
sion only in these areas cannot achieve malaria elimina-
tion rapidly enough. This is because within these areas 
there are apparently healthy individuals who have asymp-
tomatic malaria parasitaemia who sustain malaria over 
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the dry season and act as a reservoir of transmission. The 
epidemiology of malaria transmission in low-endemic 
areas is still poorly understood [5, 6], and current esti-
mates of the true burden might be very inaccurate [7].
One potential approach recently advocated by the 
WHO is to screen individuals in endemic areas for 
malaria and treat those who are positive either by 
microscopy, rapid tests, or by PCR (Focal Screen and 
Treat; FSAT) [8]. This approach assumes that most infec-
tions will be detected by such methods. The PCR meth-
ods used are more sensitive than microscopy but, as the 
blood sample volumes assayed are typically small (a few 
microlitres), they have detection limits of approximately 
1,000 parasites/mL of blood. Individuals with parasite 
densities below this remain undetected and untreated. 
An alternative more radical approach, which would treat 
effectively all parasitaemic individuals, is to treat the 
entire population in the area, a strategy applied in dif-
ferent ways over the past 100 years with varying results 
[9–12]. However recent experience with this approach is 
scarce.
In response to requests for assistance because of 
reportedly large numbers of malaria cases occurring in 
remote villages adjacent to the border with Thailand, an 
area where multi-drug resistant P. falciparum is preva-
lent an urgent assessment was conducted. Cross sectional 
surveys were conducted in three of the affected villages 
using a highly sensitive PCR detection method [7]. The 
results were presented to the communities and different 
containment strategies discussed. Village malaria workers 
were trained in detection and treatment. Malaria chemo-
prevention was endorsed by the residents of one village 
where this was possible, and its impact was assessed.
Methods
Along the Thailand-Myanmar border the transmission 
of malaria is low and seasonal [5, 13, 14]. Most clinical 
cases are seen between May and December. Incidence 
rises abruptly with the onset of the rains in April–
May each year, potentially reaching epidemic propor-
tions and then declines at the height of the rainy season 
(August–October) and then sometimes peaks again at 
the beginning of the cool season (November–December). 
Approximately half the cases are P. vivax and the other 
half P. falciparum. Plasmodium malariae and P. ovale 
infections are reported rarely. Entomological inocula-
tion rates for the two main species are typically below 2/
person/year. The Shoklo Malaria Research Unit has con-
ducted clinical and epidemiological research on malaria 
on the North Western border of Thailand for the past 
28 years and supported regional malaria control efforts, 
during which time the overall incidence of malaria has 
declined markedly, the relative proportion of P. vivax has 
increased, and resistance to mefloquine, and now to arte-
misinin has emerged [15].
Community leaders and key workers were consulted 
about the project, and approval was obtained from 
the Tak Province Community Ethics Advisory Board 
(T-CAB) [16]. The T-CAB which consist of representa-
tives from both the local ethnic Karen and Burman bor-
der communities has been the primary ethics review 
body for health care interventions along the border for 
the past 6 years [17].
Surveys were conducted in the three villages (PLU, 
WLM and TMK) located on the Thailand-Myanmar bor-
der and the need to screen everyone for malaria para-
sitaemia within a short time in the surveys was agreed. 
Blood samples (>1  mL from adults and 0.5  mL from 
children older than 5  years) were then taken from the 
participants for the qPCR assay. Children 5 years old or 
younger were not sampled. Standard malaria thick and 
thin smears were prepared and stained with Giemsa for 
all participants. Samples were taken into EDTA tubes 
transported on ice and then stored at −80  °C. All sub-
jects were examined clinically and axillary temperatures 
recorded. If patients were ill a malaria rapid test was per-
formed and appropriate treatment was given.
Measurement of parasitaemia
Standard microscopy was performed on Giemsa-stained 
thick films and the number of parasites per 500 white 
blood cells was counted. The sensitive high volume 
PCR assay has been described in detailed elsewhere [7]. 
Briefly, the DNA template for PCR detection and quan-
tification of Plasmodium was purified from the thawed 
packed red blood cells samples. The volume of each 
sample was carefully measured before DNA extraction, 
which was undertaken using a QIAgen Blood Mini kit® 
for sample volumes ≤200  µL (equivalent to 400  µL of 
whole blood assuming a normal haematocrit of 50  %), 
or a QIAgen Blood or Midi kit® for sample volumes 
between 200 and 2,000  µL packed red blood cells (Qia-
gen, Germany). The purified DNA was dried in a centrif-
ugal vacuum concentrator and then suspended in a small 
volume of PCR grade water so as to concentrate it. The 
PCR sensitivity had a lower limit of detection of only 22 
parasites per 1,000 µL of whole blood. For samples where 
the qPCR was positive an attempt was made to determine 
the Plasmodium species present using nested PCR pro-
tocols specific to P. falciparum, P. vivax and P. malariae 
as described previously [18–20]. Samples for which there 
was insufficient DNA to do this, or where no amplifica-
tion was obtained were reported as being of indetermi-
nate species.
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Provision of malaria chemoprevention
When the results of the initial surveys became avail-
able they indicated very high rates of asymptomatic 
malaria parasite carriage in all three villages (see below). 
After urgent validation and review of the PCR results 
and subsequent consultation and discussion with com-
munity leaders and the T-CAB, by April 2012 it was 
decided mutually that the best approach to reducing the 
malaria burden in the imminent malaria season was to 
strengthen local diagnosis and treatment of malaria and 
if possible to offer urgent supervised chemoprevention to 
the whole community, excluding children under 14 and 
pregnant women. It was agreed that if chemoprevention 
was provided then it would be necessary to monitor its 
acceptability and effects. However two of the three vil-
lages were inaccessible during the rainy season and so 
chemoprevention could not be deployed without the nec-
essary supervision. In the closest village (WLM), which 
could be reached, a full 3-day treatment course of dihy-
droartemisinin-piperaquine (7.5/60 mg/kg) was provided 
to all non-pregnant participants (age 14 years and above) 
at monthly intervals for 3  months (June, July, August 
2012) and a follow up malaria survey was performed in 
December 2012 to assess impact. These plans were dis-
cussed with and approved by the community and indi-
viduals who did not wish to participate were free to do so 
without affecting their access to health care and malaria 
treatments.
Results
In the 5  years before the three surveys presented here, 
the prevalence of P. falciparum and P. vivax malaria by 
microscopy in 6,943 persons in 12 villages in this region 
ranged from 1.3 to 7 % and 8.1 to 9.7 %, respectively.
The initial surveys presented here were conducted in 
May 2010 (PLU), December 2011 (WLM) and March 
2012 (TMK). The entire population present in each vil-
lage was invited to participate. In total 580 people were 
screened in PLU, 536 in WLM, and 401 in TMK (Table 1). 
This represented 580/634 (91.5 %), 536/674 (79.5 %), and 
401/678 (59.1 %) of the total village populations respec-
tively, of whom 356 (PLU), 385 (WLM) and 286 (TMK) 
provided a blood sample for qPCR.
Overall 11.6  % (67/577), 18.3  % (98/536), and 23.4  % 
(94/401) of the villagers were malaria parasite positive by 
microscopy in PLU, WLM and TMK, respectively (Fig. 1; 
Table  2). The corresponding figures for the testing by 
qPCR were 2–5 times higher: 204/356 (57.3 %), 212/385 
(55.1 %) and 195/286 (68.2 %), respectively (Table 3).
In total 611 infections were detected, but for 100 
of these the parasite species could not be determined 
because of insufficient DNA. Of the remaining 511 infec-
tions, approximately one-third were P. falciparum and 
two-thirds were P. vivax. One P. malariae infection was 
identified and 86 (14.1 %) were mixed (P. falciparum and 
P. vivax) infections. Overall the parasitaemias were low 
and 30.1 % (184/611) of the positive qPCR samples had 
parasite counts below 1,000 per mL and 4.1  % (25/611) 
had parasite densities below 100 per mL of blood 
(Table  4). Overall 72.3  % (442/611) of the infections 
Table 1 Participants in the three villages
Village 1 (PLU) May 2010 Village 2 (WLM) Dec 2011 Village 3 (TMK) May 2012
Number of participants (% of total in population)
 Adult males 177/193 (92 %) 177/190 (93 %) 75/160 (47 %)
 Adult females 169/186 (91 %) 146/201 (73 %) 90/145 (62 %)
 Children 234/255 (92 %) 213/283 (75 %) 236/373 (63 %)
 Total 580/634 (91 %) 536/674 (80 %) 401/678 (60 %)
Fig. 1 Prevalence of malaria by species in the three villages. The 
upper panel shows the distribution of the species: black: P. falciparum, 
orange: P. vivax, green: mixed infections. The lower panel shows the 
prevalence of malaria in the three villages. Blue: microscopy, and 
Green: qPCR.
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detected by qPCR had a density below 50 per microlitre 
(the lower limit of detection by microscopy). Of the 74 
samples that were positive for P. falciparum that were 
successfully sequenced for the k-13 gene, 46 (62 %) were 
mutant.
After chemoprevention
In June 2012, 562 villagers in WLM participated to the 
intervention of whom 346 provided a qPCR blood sam-
ple and 206 (36.7  %) received a treatment dose of DP 
chemoprevention. This was repeated in the following 
2 months and the corresponding numbers were 416, 270 
and 161 (38.7 %) in July and 263, 178 and 114 (43.3 %) 
in August 2012. A total 217 inhabitants received at least 
one dose of DP chemoprevention, of whom 98 (45.2 %) 
received the complete three treatment doses and 
155/217 (71.4 %) participants received two consecutive 
months of chemoprevention. Those who did not receive 
the complete course of chemoprevention either refused 
or had left the village. In December 2012 426 villagers 
participated in the final survey of whom 375 provided 
a sample for qPCR. The treatments were well tolerated 
with no serious adverse events reported. A few partici-
pants reported mild dizziness following treatment.
The results of the post-chemoprevention surveys 
conducted in June, July, August, and December 2012 
in WLM indicated an overall reduction in the preva-
lence of malaria in the population (Table 5). In July, one 
of the five P. falciparum cases was in a participant who 
had received DP in June and who was negative by PCR 
in August and December. The remaining P. falciparum 
cases (four in July and five in August) were all in people 
who had not previously received DP. Eight of the par-
ticipants to the June 2012 survey were already positive 
by qPCR in the December 2011 survey (i.e. 6  months 
earlier), five with mixed infections and three with P. fal-
ciparum. Of those with mixed infections in December 
2011, two had P. vivax, two mixed infections and one P. 
falciparum in the June 2012 survey. Of the three remain-
ing P. falciparum infections of December 2011, two had 
P. vivax and one was negative in June 2012 (Table 6). In 
the sub-group of 96 people (83 adults and 13 children) 
who received the three courses of DP and also provided 
a venous sample at each survey, the proportion of P. fal-
ciparum infections declined from 5.2  % (5/96) in June 
to nil in July, August and December while the propor-
tion of P. vivax infections declined from 27.1 % (26/96) 
to 2.1 % (8/96) in July, 2.1 % (8/96) in August and was 
13.5 % (13/96) in December (Fig. 2). The plasmodial spe-
cies could not be determined in 18.8 % (18/96) in June, 
8.3 % (8/96) in July, 12.5 % (12/96) in August and 9.4 % 
(9/96) in December 2012. During the period from June 
to October 2012 (rainy season) the number of clinical 
episodes of P. falciparum detected by the malaria post 
was over six times lower (46) than in the same period of 
the previous year (290).
Table 2 Prevalence in the three villages by microscopy
* Mixed infections are counted in both species.
** 3 slides were unreadable.
Village 1 (PLU) May 2010 Village 2 (WLM) Dec 2011 Village 3 (TMK) May 2012
Number (%) positive for P. falciparum*
 Adult males 2/176 (1.2 %) 22/177 (12.4 %) 6/75 (8.0 %)
 Adult females 3/167 (1.7 %) 2/146 (1.4 %) 7/90 (7.8 %)
 Children 0/234 (0 %) 15/213 (7.0 %) 28/236 (11.9 %)
 Total 5/577** (0.9 %) 39/536 (7.3 %) 41/401 (10.2 %)
Number (%) positive for P. vivax*
 Adult males 29/176 (16.5 %) 16/177 (9.0 %) 13/75 (17.3 %)
 Adult females 17*/167 (10.2 %) 12/146 (8.2 %) 9/90 (10.0 %)
 Children 16/234 (6.8 %) 33/213 (15.5 %) 63/236 (26.7 %)
 Total 62/577* (10.7 %) 61/536 (11.4 %) 85/401 (21.2 %)
Fig. 2 Prevalence of malaria in the 96 participants who received the 
full course of DP. Blue: P. falciparum, Red: P. vivax, Green: indeterminate 
species.
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Discussion
Malaria has been substantially underestimated in this 
area, as in other areas in this region with similar epide-
miology [7]. A high proportion of apparently healthy 
individuals living in an area conventionally classified as 
having “hypoendemic” malaria are parasitaemic. This has 
profound implications for malaria control and elimina-
tion efforts, and in particular for the urgent need to elim-
inate artemisinin resistant falciparum malaria. It is clear 
that strengthening treatment facilities (passive detection) 
or conventional active detection (FSAT) will identify only 
some of the parasitaemic individuals, and so will not 
eliminate malaria rapidly.
The experience reported here is of a malaria survey 
and intervention conducted in response to a request for 
assistance in an area where malaria epidemics are not 
uncommon. It was not a carefully designed prospective 
study so it has certain limitations, notably the low cov-
erage and short duration of follow up. Nevertheless the 
information gained was of value both for the under-
standing of malaria epidemiology and also the design 
and evaluation of control interventions. The majority of 
asymptomatic malaria parasite carriers in this area of 
low seasonal malaria transmission had parasite densities 
below those detectable by microscopy and many were 
below the limit of detection of the commonly used low 
volume (5  µL) PCR methods. It seems likely that even 
the improved detection method with a limit of detec-
tion of approximately 20 parasites/mL (corresponding 
to a total of 100,000 parasites in the blood of an adult), 
might still not capture all carriers. This level of sensitivity 
may also detect infections as they emerge from the liver 
stage development, as was observed nearly 70 years ago 
in large blood volume sub-inoculation experiments [21], 
that might self-cure. At very low parasite densities, false 
PCR positivity is clearly a major concern for epidemio-
logical assessments. The consistent negativity of control 
samples provides reassurance that the higher prevalence 
estimates are not inflated significantly. The observa-
tion that the individuals with very low parasite densities 
became negative by qPCR after treatment provides fur-
ther support that these were active low-density infections 
and not simply artefacts. The need for a relatively large 
amount of venous blood (1–2 mL in adults) for the qPCR 
assay and the requirement to process the sample within 
24 h are significant operational obstacles. This detection 
method should not be seen as a diagnostic tool for case 
detection (it is too sensitive), but as a method of detect-
ing asymptomatic malaria and thereby assessing the 
size of the sub-microscopic reservoir in the community. 
Table 3 Malaria species by sensitive PCR in the three villages
* Parasites could not be identified in 40/356 (12.4 %) and 30/385 (7.8 %) and 26/286 (9.1 %) positive samples in villages 1, 2 and 3 respectively. Mixed infections are 
counted in both species.
Village 1 (PLU) May 2010 Village 2 (WLM) Dec 2011 Village 3 (TMK) May 2012
Number (%) positive for P. falciparum*
 Adult males 21/148 (14.2 %) 42/171 (24.6 %) 21/71 (29.6 %)
 Adult females 18/127 (14.2 %) 15/130 (11.5 %) 18/90 (20.0 %)
 Children 19/81 (23.5 %) 14/84 (16.7 %) 31/125 (24.8 %)
 Total 58/356 (16.3 %) 80/385 (18.4 %) 71/286 (24.5 %)
Number (%) positive for P. vivax*
 Adult males 63/148 (42.5 %) 56/171 (32.7 %) 31/71 (43.7 %)
 Adult females 39/127 (30.7 %) 40/130 (30.8 %) 32/90 (35.6 %)
 Children 20/81 (24.7 %) 46/84 (54.8 %) 71/125 (56.8 %)
 Total 122/356 (34.3 %) 124/385 (36.9 %) 134/286 (46.9 %)
Table 4 Geometric Mean of parasitaemia by microscopy and PCR in the three villages
Village 1 (PLU) May 2010 Village 2 (WLM) Dec 2011 Village 3 (TMK) May 2012
Microscopy PCR Microscopy PCR Microscopy PCR
Geometric mean (range)  
all species
63.0 (32–256) 7.82 (0.28–186,948) 109 (16–5,888) 50.31 (0.25–751,510) 85.0 (2–4,224) 26.07 (0.11–296,713)
Geometric mean (range)  
P. falciparum
170.0 (90–256) 2.95 (0.34–5,999) 110 (16–5,792) 69.52 (0.27–751,510) 96.0 (16–4,224) 79.01 (0.25–296,713)
Geometric mean (range)  
P. vivax
47.9 (32–144) 24.38 (0.31–25,136) 109 (16–5,888) 36.78 (0.3–108,318) 79 (2–2,880) 14.79 (0.11–97,719)
Page 6 of 8Lwin et al. Malar J  (2015) 14:319 
Estimates can be achieved by sampling a small number 
of randomly selected adults. The possibility that the true 
prevalence of malaria in these villages is even higher can-
not be excluded. The high prevalence of sub-microscopic 
malaria was little influenced by seasonality whereas most 
symptomatic malaria occurs during the rainy season. 
Similar observations have been made in higher trans-
mission settings where symptomatic malaria often coin-
cides with the rains but asymptomatic carriage is much 
less affected by season. The prevalence of asymptomatic 
P. vivax was approximately twice that of P. falciparum, 
and their density profiles were approximately similar. The 
proportion of P. falciparum to P. vivax in asymptomatic 
carriers was similar to that seen in symptomatic patients 
in malaria clinics.
The discovery of a substantial number of parasite posi-
tive asymptomatic individuals was discussed with the 
affected village representatives and a joint decision taken 
to try and reduce this previously undetected burden of 
malaria. Malaria diagnosis and treatment were strength-
ened and three rounds of chemoprevention was offered 
to the whole community for the coming rainy season, 
though for logistical and security reasons this was only 
possible for one of the villages. The prevalence of P. 
Table 5 Malaria prevalence by Microscopy and PCR post-chemoprevention in WLM
Mixed infections are counted in both species.
* 2 slides were unreadable.
** 7 slides were unreadable.
*** 1 slide was unreadable.

















P. falciparum 8/560* (1.4 %) 24/346 (6.9 %) 0/409** (0.0 %) 5/270 (1.9 %) 1/263 (0.4 %) 5/178 (2.8 %) 1/425*** (0.2 %) 1/370 (0 %)
 Adult male 4/151 (2.6 %) 8/72 (11.1 %) 0/112 (0.0 %) 1/60 (1.6 %) 1/76 (1.3 %) 3/42 (7.1 %) 1/93 (1.1 %) 0/92 (0.0 %)
 Adult female 1/171 (0.6 %) 8/121 (6.6 %) 0/117 (0.0 %) 0/96 (0.0 %) 0/75 (0.0 %) 1/58 (1.7 %) 0/134 (0.0 %) 0/133 (0.0 %)
 Child 3/238 (1.3 %) 8/153 (5.2 %) 0/180 (0.0 %) 4/114 (3.5 %) 0/112 (0.0 %) 1/78 (1.3 %) 0/198 (0.0 %) 0/145 (0.0 %)
P. vivax 61/560 (10.9 %) 122/346 (35.5 %) 18/409 (4.4 %) 45/270 (16.7 %) 14/263 (5.3 %) 30/178 (16.9 %) 37/425 (8.7 %) 29/370 (7.8 %)
 Adult male 16/151 (10.6 %) 23/72 (31.9 %) 1/112 (0.9 %) 4/60 (6.7 %) 2/76 (2.6 %) 3/42 (7.1 %) 7/93 (7.5 %) 4/92 (4.3 %)
 Adult female 9/171 (5.3 %) 35/121 (28.9 %) 1/117 (0.9 %) 2/96 (2.1 %) 1/75 (1.3 %) 2/58 (3.4 %) 7/134 (5.2 %) 7/133 (5.3 %)
 Child 36/238 (15.1 %) 64/153 (41.8 %) 16/180 (8.9 %) 39/114 (34.1 %) 11/112 (9.8 %) 25/78 (32.0 %) 23/198 (11.6 %) 18/145 (12.4 %)
Indeterminate NA 57/346 (16.5 %) NA 27/270 (10.0 %) NA 27/178 (15.2 %) NA 15/370 (4.1 %)
 Adult male NA 12/72 (16.7 %) NA 7/60 (11.7 %) NA 11/42 (26.2 %) NA 4/92 (4.3 %)
 Adult female NA 23/121 (19.0 %) NA 6/96 (6.3 %) NA 5/58 (8.6 %) NA 0/133 (0.0 %)
 Child NA 22/153 (14.4 %) NA 14/114 (12.3 %) NA 11/78 (14.1 %) NA 6/145 (4.1 %)
Negative 493/560 (88.0 %) 153/346 (44.2 %) 391/409 (95.6 %) 196/270 (72.6 %) 248/263 (94.3 %) 117/178 (65.7 %) 387/425 (91.1 %) 326/370 (88.1 %)
 Adult male 131/151 (86.8 %) 32/72 (44.4 %) 111/112 (99.1 %) 48/60 (80.0 %) 73/76 (96.1 %) 25/42 (59.5 %) 85/93 (91.4 %) 84/92 (91.3 %)
 Adult female 111/171 (94.7 %) 56/121 (46.2 %) 116/117 (99.1 %) 88/96 (91.7 %) 74/75 (98.7 %) 50/58 (86.2 %) 127/134 (94.8 %) 126/133 (94.7 %)
 Child 73/238 (84.0 %) 65/153 (42.5 %) 164/180 (91.1 %) 60/114 (52.6 %) 104/112 (90.2 %) 42/78 (53.8 %) 175/198 (88.4 %) 121/145 (83.4 %)
Table 6 Details of eight participants positive by qPCR in December 2011
Case Dec 2011 June 2012 July 2012 August 2012 Dec 2012
PCR result MDA PCR result MDA PCR result MDA PCR result PCR result
1 PF Y PF N N N N Neg
2 PF/PV N PF/PV N PF/PV N N Neg
3 PF Y PF Y Neg N N Neg
4 PF/PV N PV N Neg N Neg PV
5 PF Y NEG Y Neg N N Neg
6 PF/PV N PF/PV N PF/PV N Indeterminate PV
7 PF/PV N PF N N Y PV Neg
8 PF/PV Y PV Y PV N N Neg
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falciparum malaria by microscopy and by qPCR declined 
sharply after the intervention and was still very low 
6 months later, while the prevalence of P. vivax infections 
declined initially but rose again. This is most likely due 
to relapses from liver stages. There is increasing evidence 
that P. vivax hypnozoites can remain dormant for long 
periods even in tropical areas. The elimination of hypno-
zoites would require long courses of primaquine, a drug 
associated with a significant risk of haemolysis in this 
population where the prevalence of G6PD deficiency is 
high. There were few clinical episodes of malaria detected 
during the rainy season following the intervention. How-
ever less than half of the entire population received the 
full three doses of DP, so the overall impact on malaria 
transmission was sub-optimal. This underlines the cru-
cial importance of an effective community engagement 
process in this type of intervention. Another significant 
limitation of this survey is the exclusion of young chil-
dren and pregnant women. Obviously, if elimination of 
P. falciparum malaria is the goal, these two vulnerable 
groups will have to be accommodated. Studies are on 
going to address this important question.
From an operational perspective, screen and treat 
approaches to malaria elimination are difficult, insuf-
ficiently effective, and costly. The only way to eliminate 
malaria rapidly in these populations is to treat the entire 
population with effective anti-malarial drugs. How, when 
and how often this should be done needs urgent inves-
tigation. Whether such an approach will be feasible and 
effective is not known. This region is in a race against 
time to contain and eliminate artemisinin resistance but 
the challenges are formidable. As shown in this experi-
ence, access to communities can be difficult because 
of the terrain and because of political instability. In the 
2 years that follow this intervention, a more detailed pro-
spectively designed project was undertaken in four new 
villages with the participation of local Non Governmen-
tal Organizations and Community Based Organisations. 
This ensured accessibility and participation in this politi-
cally fragmented population.
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